Podcasts about Urology

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I'll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Groin bulges, scrotal swelling, and nonpalpable testes are findings that often surface during routine well-child exams, and they can raise immediate questions for pediatricians and families alike. Is this normal? Will it resolve on its own? Or does it require surgical referral? In this episode, we take a closer look at three common genitourinary conditions in children: inguinal hernias, hydroceles, and undescended testes. We diagnose the details to help clarify the evaluation process, management strategies, and referral guidelines that every pediatrician should know.  This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. Joining us is Eric Bortnick, MD. He is a Urologist and Assistant Professor of Urology at the Yale School of Medicine.   Some highlights from this episode include:  How common these conditions are in the pediatric population  When pediatricians can make a difference in these patients lives, versus when referral is really necessary.  Key takeaways to performing a successful physical exam  Creating a safe space for proper diagnosis  For more information on Children's Colorado, visit: childrenscolorado.org. 

65% of men say they avoid seeking medical attention as long as possibleOnly 3 in 5 men go for their annual physical.And in Chicago, men are 10% less likely to have a primary care provider compared to women. And die 6 years earlier than women on average.On today's Block Club Chicago podcast, sponsored by Rush, doctor Zachary Glaser from Rush University's Department of Urology, on how 'Movember' can make a difference. Host - Jon HansenGuest - Dr. Zachary Glaser, Rush University Medical Center Want to donate to our non-profit newsroom? CLICK HEREWho we areBlock Club Chicago is a 501(c)(3) nonprofit news organization dedicated to delivering reliable, relevant and nonpartisan coverage of Chicago's diverse neighborhoods. We believe all neighborhoods deserve to be covered in a meaningful way.We amplify positive stories, cover development and local school council meetings and serve as watchdogs in neighborhoods often ostracized by traditional news media.Ground-level coverageOur neighborhood-based reporters don't parachute in once to cover a story. They are in the neighborhoods they cover every day building relationships over time with neighbors. We believe this ground-level approach not only builds community but leads to a more accurate portrayal of a neighborhood.Stories that matter to you — every daySince our launch five years ago, we've published more than 25,000 stories from the neighborhoods, covered hundreds of community meetings and send daily and neighborhood newsletters to more than 130,000 Chicagoans. We've built this loyalty by proving to folks we are not only covering their neighborhoods, we are a part of them. Some of us have internalized the national media's narrative of a broken Chicago. We aim to change that by celebrating our neighborhoods and chronicling the resilience of the people who fight every day to make Chicago a better place for all.

We have relied on PSA for decades, but what's next in precision screening for prostate cancer? In this episode of BackTable Urology, Dr. Jason Hafron from the Michigan Institute of Urology joins host Dr. Ruchika Talwar to discuss the evolving role of biomarkers and artificial intelligence in prostate cancer screening.---This podcast is supported by:Cleveland Diagnosticshttps://www.isopsa.com/---SYNPOSISTogether, Dr. Hafron and Dr. Talwar examine the ongoing challenges of PSA testing and the promise of next-generation blood-based biomarkers, including 4Kscore and IsoPSA tests. They explore how these advancements are reshaping detection, diagnosis, and risk stratification. The episode also highlights how these tools may improve active surveillance protocols, reduce unnecessary biopsies, and better personalize prostate cancer management for better outcomes.---TIMESTAMPS0:00 - Introduction2:23 - Limitations of PSA10:21 - Limitations of MRI18:08 - Overview of Biomarkers (IsoPSA, 4K, PHI, SelectMDx, MIPS, ExoDx)26:30 - Artificial Intelligence---RESOURCESProstate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trialhttps://jamanetwork.com/journals/jama/fullarticle/2817323 Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSAhttps://pubmed.ncbi.nlm.nih.gov/36965817/ Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyhttps://pubmed.ncbi.nlm.nih.gov/35840465/

In this conversation, Dr. Dean Elterman, Associate Professor of Urology at the University of Toronto and a sub-specialist in functional urology, discusses benign prostatic hyperplasia (BPH), a common condition affecting men as they age. He explains the causes, symptoms, and various treatment options available, including medications, traditional surgeries, and minimally invasive procedures. The discussion also touches on the role of AI in improving treatment outcomes and the importance of lifestyle changes in managing BPH. Dr. Elterman emphasizes the need for awareness and proactive management of urinary symptoms.#prostatehealth

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Nicholas James (GB) on the results of the final survival analysis from the BladderPath trial, a randomised comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 3, “Women surgeons in Asia – Pioneering progress” of the series “Women in Urology: Dare to Thrive”, Dr. Kinju Adhikari (NP) and Dr. Steffi Kar Kei Yuen (HK) share their experiences as pioneering female surgeons in Asia. Dr. Adhikari recounts her path from Nepal to becoming a leading onco-urologist and robotic surgeon in India, while Dr. Yuen reflects on her work at the Chinese University of Hong Kong and the evolving role of women in urology across the region. Together, they discuss the challenges of gender bias, the importance of perseverance and the growing number of women entering surgical specialities.They highlight the vital role of mentorship, collaboration and supportive professional networks in fostering women's progress in medicine. Both speakers emphasise that while representation has improved, barriers such as societal expectations and limited opportunities still exist. Their conversation explores how passion for patient care and clinical excellence can co-exist with advocacy for equality.Through their exchange, the episode celebrates the determination of women surgeons shaping the future of urology in Asia and inspires the next generation to follow their lead with confidence and purpose.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

October 24, 2025 In episode 264 of the Urology Coding and Reimbursement Podcast, Scott and Mark Painter sit down with Ken Mitchell, PA-C, a nationally recognized expert in men's health and a champion for advanced practice providers (APPs) in urology. Ken shares insights on the growing urology workforce shortage, the evolving role of APPs, and recent payer challenges—like restrictions on APP-administered Xiaflex in Arkansas. He also introduces his nonprofit, Gynecology, which promotes men's health education and training. This episode is a must-listen for practices navigating workforce limitations, payer pushback, and the future of urologic care.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

More on this awareness campaign by the UOAA at ostomy.org/take-action/ as referenced on OneLegUpAlex !

More on this awareness campaign by the UOAA at ostomy.org/take-action/ as referenced on OneLegUpAlex !

More on this awareness campaign by the UOAA at ostomy.org/take-action/ as referenced on OneLegUpAlex !

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Prof. Maria De Santis (DE) about the result of the final analysis of the phase III, open-label, randomised POTOMAC trial: Durvalumab (D) in combination with Bacillus Calmette-Guérin (BCG) for BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC). This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this episode, Prof. Scott Tagawa (US), a medical oncologist at Weill Cornell Medicine in New York, discusses the results of PSMAddition - a phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Dr. Dipen J. Parekh is a globally renowned urologic oncologist, healthcare innovator, and leader in academic medicine. He was appointed Executive Vice President for Health Affairs at the University of Miami and Chief Executive Officer of its health system (UHealth) on June 1, 2025. He remains Founding Director of the Desai Sethi Urology Institute and is an accomplished researcher and professor at the University of Miami Miller School of Medicine who holds the Victor A. Politano Endowed Chair in Urology and is widely celebrated for his groundbreaking contributions to the field of robotic-assisted urologic oncology. Having served as Chief Operating Officer of UHealth from 2020-2025, Chief Clinical Officer from 2017-2020, Chairman of the Department of Urology since 2012, Executive Dean of Clinical Affairs at the University of Miami Miller School of Medicine, and Director of Robotic Surgery for UHealth, Dr. Parekh brings a wealth of academic, clinical, administrative, and institutional experience to the role.Over the course of his career, Dr. Parekh has performed more than 6,000 robotic urologic cancer surgeries, making him one of the most experienced practitioners worldwide. He led the groundbreaking RAZOR trial, published in The Lancet in 2018, which established the efficacy of robotic-assisted radical cystectomy as comparable to open surgery for bladder cancer. He is an NCI funded surgeon scientist with over 200 peer reviewed publications in urologic oncology. His dedication to innovation has also included establishing advanced robotic surgery programs in academic centers across the globe.

UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Christof Vulsteke (BE) on the design and results of the phase III KEYNOTE 905/EV303 study: Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible. This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 2, “Academic career – The long and winding road?” of the series “Women in Urology: Dare to Thrive”, Dr. Amelia Pietropaolo (GB) and Dr. Carmen Mir (US) explore the opportunities and obstacles women face in building an academic career in urology. They highlight the persistence of gender gaps in leadership, the structural barriers that limit women's access to networks and senior positions, and the pressures of balancing academia with personal life.Both speakers emphasise the value of mentorship and sponsorship, sharing how role models and supportive colleagues helped them progress, while also reflecting on moments when barriers or cultural biases made the journey more difficult. They discuss positive shifts in recent years, including greater awareness of diversity at conferences and in academic societies, while questioning whether current measures go far enough.Their conversation also touches on the importance of collaboration, networking, and building resilient research communities that encourage young urologists to thrive. Finally, they share personal advice for the next generation: seek mentors, stay curious, and remember why you chose research in the first place.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

¿Te levantas cada noche al baño y ya no recuerdas la última vez que dormiste del tirón?

August 2025 brings another fantastic edition of European Urology! Here on the European Urology Podcast we bring you selected highlights from the journal each month with some great guests. We have selected two key papers (details below) from this month's journal, including interviews with key authors. European Urology Podcast co-Hosts Professor Declan Murphy (Melbourne, Australia), and Dr Nikita Bhatt (Newcastle, UK) are joined by Dr Eoin Dinneen (Melbourne, Australia) who gives a quick summary of other highlights in this month's edition.Podcast Priority Papers1 . Magnetic Resonance Imaging–led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study Featured author - Prof Carolione Moore (London, UK)2. Robot-assisted Single-docking Approach for Level III Inferior Vena Cava Tumor Thrombectomy: Surgical Technique and Outcomes Featured author - Dr Xuepei Zhang (Zhengzhou, China - unable to attend)Full index to European Urology August 2025 Even better on our YouTube channelEuropean Urology Podcast is produced by the GU Cast team in Melbourne, Australia

Board-certified urologist Dr. Jason B. Carter explains his role in the diagnosis of testicular cancer."It's important to understand that when you have a diagnosis like testicular cancer, to some degree, the urologist may be the quarterback in the beginning. With testicular cancer, the urologist is going to be the one you meet, get the initial procedures done, and do the post-op follow-up."I'm very fortunate to have an excellent radiation oncologist that I work with, and very fortunate to have a couple of very, very good medical oncologists that I work with."Definitely anytime you have any kind of cancer, including testicular cancer, it is always a team approach." He shares his insights on treating testicular patients at Unity Urology, his practice in East Tennessee. He has been providing quality urologic care since 2003 and opened Unity Urology in 2006 in Greenville, Tennessee. Other urologic conditions to know about: Dr. Carter talks about other urologic conditions such as low testosterone, other hormone therapies for men and women, infertility, incontinence, and erectile disfunction. He is a medical advisor for Aeroflow Urology.Dr. Carter's medical degree is from East Tennessee University. He completed a residency at the University Hospital and clinics in Columbia, Missouri. He is board-certified in urology by the American Board of Urology and a member of the American Urological Association and the Tennessee Medical Association. Send us a textSupport the showFind us on Twitter, Instagram, Facebook & Linkedin. If you can please support our nonprofit through Patreon.

Developed by the AUA Residents and Fellows Committee, each episode of the Training Transformed podcast series features an interview with a urology faculty member and resident physician surrounding an innovative facet of resident education at their institution. Tune in for our second episode as moderator, Dr. Kayla Graham chats with Dr. Ryan Steinberg and Dr. Brent Yelton about the Point-of-Care Ultrasound (POCUS) curriculum developed at the University of Iowa.

The Urological Association of Asia (UAA) Annual Meeting is always a great cultural event with a focus on the local community. And Taipei certainly put on a great show! Lots of fantastic entertainment and great local cuisine, plus of course a great scientific program, with a focus on AI, single port robotic surgery, novel robot systems, and lots more across the breadth of Urology.Join hosts Renu Eapen and Declan Murphy, who bring you a great flavour of UAA in Taipei, speaking to many local and international guests. Even better on our YouTube channelGU Cast Conference Highlights are supported by our Conference Highlights Partner, Bayer China. 

Oct. 16, 2025 ~ Urological issues aren't just a concern for men—up to 60% of women will experience conditions like UTIs, incontinence, pelvic pain, or sexual dysfunction. Lloyd Jackson explores how Dr. Priya Patmanabhan at Corewell Health's Women's Urology Center in Royal Oak is changing the narrative. Dr. Patmanabhan explains how her multidisciplinary approach—combining urology, gynecology, pain psychology, and physical therapy—helps women feel heard and supported. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.

Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?

Jim and Lucinda discuss urological issues in rural settinsg

Urinary incontinence affects millions of women, yet many continue to suffer in silence due to stigma or the misconception that it's just a normal part of aging. Bladder control issues can impact women of all ages, and they are highly treatable, and there are real solutions that can help. On this episode of the Healthier You Podcast, Dr. Ashlee Williams welcomes Dr. Nwamaka Fadahunsi, a board-certified urologist at Kaiser Permanente, to discuss the causes of urinary incontinence and the many tools available to treat it. Dr. Fadahunsi explains the differences between stress and urge incontinence, debunks common myths, and offers practical guidance on what women can do at home. She also outlines the full range of treatment options, including physical therapy, medications, and outpatient procedures, helping women regain control and confidence without relying on pads or assuming surgery is the only answer.  Learn more about Nwamaka Fadahunsi, MD 

"Give Me the Green Life” isn't just a song lyric — it's a movement toward living fully, consciously, and healthily.In this powerful and revealing episode, we dive deep into the male side of fertility — a topic that's been ignored for far too long.Our expert guest joins us to discuss why sperm counts are dropping globally, what lifestyle factors are driving this crisis, and how men can reclaim their reproductive health naturally. From testosterone therapy pitfalls to the truth about saunas, marijuana, and modern stress, this episode uncovers it all.Dr. Justin Houman is a Board-Certified Urologist and fellowship-trained Men's Sexual and Reproductive Health specialist based in Los Angeles. His practice focuses on male fertility, erectile dysfunction, testosterone optimization, sexual performance, Peyronie's Disease, and minimally invasive procedures such as vasectomy reversals and penile implants.As an Assistant Professor of Urology at Cedars-Sinai Medical Center, Dr. Houman is dedicated to mentoring future physicians and advancing men's health through research, innovation, and education. His work has been featured in leading journals, including JAMA and the Journal of Sexual Medicine, and he has presented internationally on topics ranging from male fertility to the impact of wearable technology on health.A second-generation urologist, Dr. Houman completed his medical training at the University of Rochester and Cedars-Sinai, followed by a fellowship in Male Reproductive Medicine and Surgery at UCLA. Fluent in English, Spanish, and Farsi, he is committed to helping men enhance their quality of life through personalized, evidence-based care.

In Episode 1, “Leadership ladder: Creating your path” of the series “Women in Urology – Dare to Thrive”, Dr. Amelia Pietropaolo (GB) and Prof. Maria Ribal (ES) discuss the challenges and opportunities of pursuing leadership in a traditionally male-dominated specialty. Drawing on their personal journeys, they reflect on the persistence of gender stereotypes, the experience of imposter syndrome, and the importance of building confidence through knowledge, hard work, and supportive networks.Their conversation emphasises that leadership is not about following a rigid master plan but about vision, long-term investment, and trust in one's capabilities. Both speakers highlight the transformative role of mentorship and sponsorship, the value of inclusive groups in attracting more women into urology, and the importance of respecting individuality rather than conforming to stereotypes. Practical advice for young urologists includes taking small steps, embracing networking opportunities, and being unafraid to volunteer or step outside of one's comfort zone.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In today's episode, we had the pleasure of speaking with Joseph Jacob, MD, MCR, about the FDA approval of the gemcitabine intravesical system (formerly TAR-200; Inlexzo)​ for the treatment of patients with BCG-unresponsive non–muscle-invasive bladder cancer. Dr Jacob is an associate professor of urology and the director of Urologic Oncology in the Department of Urology at State University of New York Upstate Medical University in Syracuse. In our exclusive interview, Dr Jacob discussed the significance of this approval, key efficacy findings from the pivotal phase 2b SunRISe-1 trial (NCT04640623), and the TAR-200 administration procedure, which he describes as straightforward for practitioners and convenient for patients.

Enuresis, or bedwetting, is one of the most common concerns encountered in pediatrics. It can present as nighttime bedwetting, daytime urinary accidents, or a combination of both. Oftentimes, families and clinicians are left wondering what's typical and what's considered concerning. In this episode, we focus on the evaluation and management of enuresis in children. Each case is influenced by a range of factors including fluid intake, bowel habits, sleep quality and lifestyle routines. While first-line, non-pharmacologic strategies are the cornerstone of care, effective treatment requires attention to detail and a comprehensive approach. This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. In this episode, we are joined by Julie Cheng, MD, an Assistant Professor of Urology at Seattle Children's Hospital and the University of Washington.  Some highlights from this episode include:  Differentiating between types of enuresis  How key elements in pediatric history and physical examination can help diagnose the problem  Evidence-based first-line interventions and when to escalate care  The role behavioral factors, such as sleep or screen time, play in enuresis  For more information on Children's Colorado, visit: childrenscolorado.org. 

October 3, 2025 In this episode, Scott, Mark, and Ray Painter discuss two timely and important topics. First, they break down the current government shutdown and its effects on Medicare claims processing, including the 10-day hold issued by CMS to allow MACs to adjust their systems—especially around telehealth billing. They offer practical recommendations for urology practices, including billing guidance and the use of ABNs during the shutdown.Then, the discussion shifts to artificial intelligence in healthcare. After attending multiple urology meetings and AI sessions, Scott and Mark share real-world observations on how AI is being used across the urology landscape—from ambient documentation tools to claims scrubbing and patient scheduling. They emphasize the importance of human oversight, expertise, and carefully evaluating AI partners before implementing tools in your practice. Ray adds his perspective on the ongoing need for human knowledge and caution when embracing new technology.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of Better Edge, Jennifer Miles-Thomas, MD, moderates a thoughtful conversation with Anthony Schaeffer, MD, discussing complicated urinary tract infections (cUTIs) and their management. Dr. Schaeffer, who contributed to the recent IDSA guidelines on cUTIs, emphasizes the need to understand underlying causes of recurrent infections rather than treating them as isolated events. The conversation explores critical topics such as antibiotic resistance, effective treatment strategies and the importance of early intervention in febrile cases.

Developed by the Society of Academic Urologists in partnership with the American Urological Association, the SAU/AUA Urology Match Insider series provides medical students interested in the field of urology an inside look into the Urology Residency Match process. In this episode, medical student, Irene Choi, sits down with Dr. Justin S. Han and Dr. Jennifer K. Yates to discuss ways medical students can prepare for their match interviews. 

Episode 2 of our monthly GU Cast Journal Club and today we focus on two key papers from recent times - the TRANSLATE trial of transperineal vs transrectal biopsy, and Keynote-564 on the role of adjuvant pembrolizomab following nephrectomy.   After great feedback from last month's launch episode, we are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and  Declan Murphy Links to papers and previous podcasts below:1. Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial Lancet Oncology 2025GU Cast on TRANSLATE 2. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma NEJM 2024GU Cast on K-564 OS paper GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.Even better on our YouTube channelAbout GU Cast Journal Club:Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology. The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner. The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

In a conversation with CancerNetwork® following the FDA approval of the gemcitabine intravesical system (Inlexzo; formerly TAR-200) for patients with high-risk, Bacillus Calmette-Guérin (BCG)–unresponsive non–muscle-invasive bladder cancer (NMIBC), Gary Steinberg, MD, discussed how this regulatory decision may impact the treatment paradigm. Steinberg, a professor in the Department of Urology at Rush University, highlighted an unmet need for those with BCG-unresponsive, high-grade NMIBC. With a different mechanism of action compared with prior therapeutic choices in the field, he stated that the gemcitabine intravesical system may allow patients and physicians to benefit tremendously. Based on supporting data from the phase 2 SunRISe-1 trial (NCT04640623), he described how the gemcitabine intravesical system may replace prior standards such as intravesical gemcitabine plus docetaxel. The conversation also touched upon considerations for preventing the risk of progression to metastatic disease with delayed cystectomy, as Steinberg emphasized following up with patients via cystoscopies, urinary cytologies, CT scans, or MRI imaging after treatment with the intravesical system. Steinberg also detailed strategies for mitigating urinary frequency, dysuria, and other toxicities associated with the therapy. He noted a “fine line” regarding bladder medication administration to older patient populations, as these practices may cause adverse effects such as dry mouth, constipation, and blurry vision. Looking ahead, Steinberg illustrated a need to clarify the immunologic effects of regimens like the gemcitabine intravesical system, which can inform the use of additional therapeutic combinations down the road. He highlighted how other novel agents like cretostimogene grenadenorepvec (CG0070) may further improve outcomes in the NMIBC landscape. “One of the key questions that we all need to ask with all our treatments is not about the patients who respond, but about the patients who do not respond,” Steingerg stated regarding the potential next steps for research. “We can begin to understand mechanisms of resistance so that we can target those mechanisms of resistance and treat them better.” Reference U.S. FDA approval of INLEXZO (gemcitabine intravesical system) set to transform how certain bladder cancers are treated. News release. Johnson & Johnson. September 9, 2025. Accessed September 22, 2025. https://tinyurl.com/4zjz22z7

In Episode 3 "Pharmaceutical preventative measures" of the series "How to prevent anxiety in children undergoing urological procedures", MSc. Gülhan Karaöz-Bulut (NL) and Dr. M. İrfan Dönmez (TR) discuss how medications can support anxiety reduction in paediatric urological care. They begin by emphasising that sedation should not be a goal on its own but part of a broader, child-centred strategy aimed at preventing trauma and building trust. The episode reviews several commonly used agents - nitrous oxide, midazolam, dexmedetomidine, clonidine and ketamine - with clear explanations of their benefits, limitations, and suitability for different procedures.The speakers provide guidance on how each medication affects the child's experience, with practical considerations such as onset time, duration, side effects and how they may impact diagnostic results. Special attention is given to the impact of sedatives on urodynamic studies, highlighting where certain agents (like dexmedetomidine or ketamine) may alter bladder function. They also address administration methods, such as intranasal and oral routes, and the importance of planning around food intake and hydration.Throughout, the discussion underscores that medication should be tailored to the individual child and procedure, always supported by experienced clinical staff. The episode closes with a strong reminder that safe and effective sedation enhances both procedural success and the child's well-being.*See references and additional research information hereFor more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

September 26, 2025 In this episode, Scott, Mark, and Ray discuss the looming federal government shutdown and how it could impact urology practices—especially telehealth services. They explain the latest developments in Washington, what Medicare and Medicaid payments will look like during a shutdown, and offer practical guidance for handling telehealth visits, front-office operations, and prior authorizations. Mark shares specific strategies and options for practices, including use of ABNs and billing considerations for Medicare Advantage and traditional Medicare patients. The episode wraps with insights on how the shutdown might delay CMS's final rule and the broader implications for AI, reimbursement, and practice management.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

Dr. Joseph Dankoff of Summa Health discusses ExactVu, a new technology for prostate screening.

We're kicking off the seventh season with a straight-talking guide to men's health that every family should hear. Our guest is Dr. Ofer Gofrit, chair of the Urology Department at the Hadassah Medical Organization.

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I'm joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today's standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.Time-Stamped Highlights00:00 – Why fewer incisions + faster recovery are now real in prostate surgery05:40 – Work–life changes that improved health (sleep, exercise, biking)09:10 – Open vs. robotic: why reproducibility (teachability) matters11:05 – Robotics adoption curve: from early resistance to mainstream19:05 – Outcomes today: continence and erections after modern surgery20:10 – “Yes, I'm a surgeon—and here's my bias.” Radical honesty with patients22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT34:00 – Dexterity & visualization: why robots spare nerves with less trauma35:10 – Real-time margin assessment during surgery to reduce positives40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential52:30 – How to find Dr. Stifelman & closing advice

Dr. Andrew Harris and Dr. Kate Kraft, the previous and current chairs of the Workforce Task Force, explore how AUA Census data reflects the evolving landscape of urology. From the decline of solo practice to the growing need for rural access and the challenges of residency training, they discuss the factors shaping today's workforce and what it means for the future of patient care.

The Skin Real app is officially LIVE! Download it now. Download my Free Guide 'In My Perimenopause Era' Download the Ultimate Affordable Skincare Guide When was the last time you thought about your vulvar health? If your answer is “never,” you're not alone. Most women avoid talking or even thinking about this part of their body, but during perimenopause and menopause, changes in vulvar and vaginal health can have a huge impact on your comfort, confidence, and quality of life. In this episode, I sit down with Dr. Diana Londoño, a urologist who is breaking the silence on intimate health. We talk about the changes estrogen loss brings—from dryness, itching, painful sex, and recurrent UTIs to the lesser-known issues like bladder urgency and vulvar atrophy. She also explains how simple solutions like vaginal estrogen cream, hormone therapy, and lifestyle tweaks can protect your vulvar health and prevent years of suffering. ✨ Key Takeaways: Why vulvar health is central to your bladder, vaginal, and sexual health during menopause. How to know if your symptoms are normal aging or a red flag that needs further evaluation. The connection between UTIs, GSM (genitourinary syndrome of menopause), and vulvar atrophy. Why vaginal estrogen is safe, preventative, and worth considering even if you're not sexually active. How stress and mindset affect bladder symptoms and overall well-being. If you've ever felt embarrassed, ignored, or confused about what's happening “down there,” this episode will give you clarity and confidence. Dr. Diana Londoño is a Board-Certified Urologist and one of the 10% of urologists in the US who are women and the 0.5% who are Latinx and women.  She is originally from Mexico City and attended Claremont McKenna College for her undergraduate studies and then went on to attend UCLA for medical school.  She completed a 6-year residency in Urology at Kaiser Permanente in Los Angeles.   She has experienced burnout twice, which has led her to write and speak about it to raise awareness and help others. She has published multiple articles in prominent medical platforms, including Medscape, Doximity, Kevin MD, Men's Health, Giddy.com, and WebMD, among others. She is also a contributing author to the books “Thriving After Burnout” and “Medic S.O.S.”  She has also been a guest on numerous podcasts, discussing various topics, including wellness, stress, spirituality, and energy.   Her burnout journey led her to become a certified life coach and founder of Physician Coach Support.com, a peer support platform she ran for 3 years. In 2022, she received the Los Angeles County Medical Association Physician Leadership Award for her work.    She is an international speaker and guest on multiple podcasts, discussing topics such as wellness, boundaries, ego, humanity in medicine, mindset, and mindfulness. She has also been featured on TV on Univision, Telemundo, Mundo Fox, CNN Latino, KCET, and ABC News as a health consultant discussing urological topics.   She is also a Reiki Master, a Pranic Healer and the mother of two determined and joyful 7- —and 9-year-old girls, Daniela and Paloma.   Follow Dr. Londoño here:   Website -https://dianalondonomd.com/ LinkedIn - https://www.linkedin.com/in/dianalondonomd/ Instagram - https://www.instagram.com/dianalondonomd/ YouTube - https://www.youtube.com/@dianalondonomd   Want more expert skin advice without the overwhelm? Subscribe to The Skin Real Podcast wherever you listen, and visit www.theskinreal.com for dermatologist-backed tips to help you feel confident in your skin—at every age. Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ Visit Dr. Mina at Baucom & Mina Derm Surgery Website: atlantadermsurgery.com Email: scheduling@atlantadermsurgery.com Call: (404) 844-0496 Instagram: @baucomminamd Thanks for tuning in. And remember—real skin care is real simple when you know who to trust. Disclaimer: This podcast is for entertainment, educational, and informational purposes only and does not constitute medical advice.      

There is a new treatment option available now that can precisely target prostate lesions with electrical pulses, while helping preserve sexual function and urinary control. Whether you or a loved one has prostate disease, or you are a urologist considering this technology for your practice, you will not want to miss today's discussion on this innovative new option. September is Prostate Cancer Awareness Month, so we have a special episode today to kick it off. We are excited to welcome the distinguished urologist, Dr. Spencer Krane, to the Prostate Health Podcast. Dr. Krane is the Chief of Urology at the US Department of Veterans Affairs in New Orleans, Louisiana. He specializes in personalized medicine for patients with urologic malignancies, aiming to use new biomarkers, genomic classifications, epigenetic signatures, and advanced imaging modalities, including MRI-guided prostate biopsies, to offer his patients individualized care that improves cancer outcomes while minimizing therapy side effects. Dr. Krane has published extensively in urologic journals, and his work was selected to provide guidelines for urologic care. He has 50 peer-reviewed articles in national and international journals and has presented his work internationally, from Chile and Rome to Taiwan, as well as across the United States. We are excited to welcome him today to share his experience with the innovative new NanoKnife system as a treatment option for men with prostate tumors.  It is exciting to see ongoing innovation in the technology we have available for men with prostate tumors. For the appropriate candidates, this minimally invasive option offers precise targeting of the lesion while helping preserve both sexual function and urinary control.  Pertinent disclosure for today's episode – Dr. Krane is a paid consultant for AngioDynamics, Inc., which manufactures and sells the NanoKnife System. The views, information, and opinions expressed in this podcast are solely those of Dr. Krane, and does not necessarily represent those of AngioDynamics, Inc., its affiliates, or subsidiaries.  Show Highlights: Dr. Krane reviews the concept of targeted focal therapy and explains what  the NanoKnife system is Who is an ideal candidate for irreversible electroporation with the NanoKnife system? The advantages and features of the NanoKnife system   Does prostate size or shape limit the candidacy for IRE with the NanoKnife system? Would prostate anatomies on the MRI or biopsy exclude a patient from NanoKnife therapy? Dr. Krane explains how long it takes to resolve the initial decrease in sexual ability after NanoKnife therapy.   Why many patients experience improved urinary function in the long term after having NanoKnife therapy Dr. Krane clarifies the time it takes to resolve the initial decrease in sexual ability after being treated with NanoKnife therapy.   Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd.  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on X and Instagram  Sign up for the Prostate Health Academy   You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.  

AUA2025: Key Takeaways: Female Urology Highlights Presenter: Mitch G. Goldenberg, MD & Kathleen Kobashi, MD, MBA, FACS

This week on Health Matters, Courtney talks with urologic oncologist Dr. Michael Feuerstein of Columbia and NewYork-Presbyterian The One, a new center for advanced care in Westchester, to discuss the importance of screening for prostate cancer. Dr. Feuerstein explains how blood tests work to detect prostate cancer, explores the latest advancements in treatment, and debunks common myths and misunderstandings about prostate health. ___Dr. Michael Feuerstein, MD, MPH, is the chief of urology at NewYork-Presbyterian Westchester and assistant professor in the Department of Urology at Columbia University Vagelos College of Physicians and Surgeons. Dr. Feuerstein is a board-certified urologist with over ten years of experience, specializing in minimally-invasive surgery for prostate, kidney, and bladder cancer. He received his medical degree and completed his urology residency training at Albany Medical Center. He completed a two-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center and received a master's degree in public health at the Columbia Mailman School of Public Health. Dr. Feuerstein's research focuses on improving quality of care and quality of life for patients diagnosed with urologic cancers. Dr. Feuerstein provides care at NewYork-Presbyterian The One, a state-of-the-art center for advanced care with doctors from Columbia in Westchester. The facility offers adult and pediatric care spanning more than 90 specialties and subspecialties, so patients can find the care they and their families need in one convenient location.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Darshali Vyas is a pulmonary and critical care fellow at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.A. Vyas, L.G. Eisenstein, and D.S. Jones. The Race-Correction Debates — Progress, Tensions, and Future Directions. N Engl J Med 2025;393:1029-1036.

In this episode, Justin talks with Kelly Dugan, a nurse practitioner who spent years in urology before realizing the field had an untapped opportunity: bringing urology consults directly to nursing homes and assisted living facilities. Kelly shares her journey from ER nurse to private practice, what it was like getting bought out by private equity, and why she's now building her own mobile urology service.They discuss the realities of credentialing, malpractice insurance, and billing, but Justin emphasizes a key lesson, don't get stuck on small details. The most successful NPs focus on patient care, customer service, and getting started. If you're an NP looking to launch a niche practice or escape the corporate grind, this episode will inspire you to take the leap.

In this episode, Amber Walsh, Partner at McGuireWoods LLP, shares insights on the evolving physician practice management sector with a focus on urology.